Topotecan and Radiation Therapy in Treating Patients With Solid Tumors or Lymphoma

Completed · Phase 1

Conditions studied: Esophageal Cancer, Lung Cancer, Lymphoma

In brief

Phase I trial to study the effectiveness of topotecan and radiation therapy in treating patients who have solid tumors or lymphoma. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage cancer cells. Combining chemotherapy with radiation therapy may kill more cancer cells.

Key facts

Study ID

NCT00002625

Run by

National Cancer Institute (NCI)

People needed

5

Starts

1995-03-01

Expected to finish

2000-09-01

Last updated by the study team

2013-02-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of Wisconsin Comprehensive Cancer Center — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.